Sarepta
Sarepta21
Sarepta
Biopharmaceutical company focused on developing RNA-targeted therapies for rare genetic diseases.
About
What does Sarepta do?
Sarepta Therapeutics is a biopharmaceutical company dedicated to discovering, developing, and commercializing RNA-targeted therapeutics for patients with rare genetic diseases. Their primary focus is on Duchenne muscular dystrophy (DMD), a devastating and life-limiting genetic disorder. Sarepta's innovative approach utilizes various RNA-based technologies to address the underlying genetic causes of these diseases.
Where is Sarepta headquartered?
Sarepta is headquartered in Cambridge, United States.
What industry does Sarepta operate in?
Sarepta operates in Biotech, MedTech, HealthTech, Drug Discovery, Clinical Trials, Genomics.
How many employees does Sarepta have?
Sarepta has approximately 1,162 people on record.
Ship of Theseus is developing a fleet of biologics based on the homeobox (HOX) family of transcription factors to create novel pharmaceuticals.
An independent research reference providing accessible, accurate, and transparent information on bioactive peptides and peptide science.
Provider-supervised peptide therapy, NAD+ support, and cognitive enhancement for cellular renewal, recovery, and healthy aging.
Leading AI agency in Guwahati specializing in biological intelligence, generative AI, and regulatory systems for Asia's underrepresented populations.
Spearmint Resources Inc. is a Canadian mineral exploration company focused on lithium, gold, and antimony projects.
Eccoscience is a startup focused on developing AI-powered solutions for scientific research and discovery.
Feef is a voice-native AI agent that designs personalized fitness, nutrition, supplement, and recovery protocols, integrating them directly into your calendar.
Longevity and metabolic health platform offering personalized insights and interventions.
An entrant is a company tagged Biotech whose domain was first registered in the window, counted from registry records in the StartupHub directory. 3 of them registered in the last 30 days. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
“Sarepta Therapeutics is a commercial-stage biopharmaceutical company that focuses on the discovery and development of RNA-targeted therapeutics, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. $SRP…”
View on RedditSome comments are pulled from public discussions around the web (look for the source icon). Quotes are excerpts; click through to read the full thread.